Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin T Jordan

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Blood|February 15, 2022
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trialMatthew J Frigault, Jorg Dietrich, Kathleen Gallagher, et al.
Neuro-Oncology|December 15, 2025
Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant GliomaGilbert Youssef, Elisa Aquilanti, Julie J Miller, et al.
Neuro-Oncology|July 4, 2023
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cellsPhilipp Karschnia, Isabel C Arrillaga-Romany, April Eichler, et al.
Blood|March 18, 2021
A rapid genotyping panel for detection of primary central nervous system lymphomaMihir Gupta, Evan J Burns, Nicholas Z Georgantas, et al.
Cancer Discovery|January 4, 2023
Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNAIsidro Cortes-Ciriano, Christopher D Steele, Katherine Piculell, et al.
Neuro-Oncology Advances|February 6, 2025
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomesTyler A Lanman, Gilbert Youssef, Raymond Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2018
Genotype-targeted local therapy of gliomaGanesh M Shankar, Ameya R Kirtane, Julie J Miller, et al.
Blood|May 22, 2024
Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphomaMihir Gupta, Joseph D Bradley, Elie Massaad, et al.
Neurology|August 17, 2021
Contemporary Neuroscience Core Curriculum for Medical SchoolsDouglas J Gelb, Jeff Kraakevik, Joseph E Safdieh, et al.
The Oncologist|July 19, 2022
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare NetworkDora Dias-Santagata, Rebecca S Heist, Adam Z Bard, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Blood|February 15, 2022
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trialMatthew J Frigault, Jorg Dietrich, Kathleen Gallagher, et al.
Neuro-Oncology|December 15, 2025
Prognostic Significance of MGMT Promoter Methylation Status in IDH-mutant GliomaGilbert Youssef, Elisa Aquilanti, Julie J Miller, et al.
Neuro-Oncology|July 4, 2023
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cellsPhilipp Karschnia, Isabel C Arrillaga-Romany, April Eichler, et al.
Blood|March 18, 2021
A rapid genotyping panel for detection of primary central nervous system lymphomaMihir Gupta, Evan J Burns, Nicholas Z Georgantas, et al.
Cancer Discovery|January 4, 2023
Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNAIsidro Cortes-Ciriano, Christopher D Steele, Katherine Piculell, et al.
Neuro-Oncology Advances|February 6, 2025
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomesTyler A Lanman, Gilbert Youssef, Raymond Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2018
Genotype-targeted local therapy of gliomaGanesh M Shankar, Ameya R Kirtane, Julie J Miller, et al.
Blood|May 22, 2024
Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphomaMihir Gupta, Joseph D Bradley, Elie Massaad, et al.
Neurology|August 17, 2021
Contemporary Neuroscience Core Curriculum for Medical SchoolsDouglas J Gelb, Jeff Kraakevik, Joseph E Safdieh, et al.
The Oncologist|July 19, 2022
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare NetworkDora Dias-Santagata, Rebecca S Heist, Adam Z Bard, et al.
Pageof 10